Jackson Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,747
Closed -$526K 167
2025
Q2
$526K Buy
4,747
+633
+15% +$67.4K 0.06% 111
2025
Q1
$461K Buy
+4,114
New +$425K 0.06% 119
2020
Q4
Sell
-30,788
Closed -$1.95M 131
2020
Q3
$1.95M Buy
30,788
+2,822
+10% +$196K 0.29% 74
2020
Q2
$2.15M Buy
27,966
+644
+2% +$49.4K 0.38% 61
2020
Q1
$2.21M Buy
+27,322
New +$1.89M 0.46% 47
2016
Q4
Sell
-14,824
Closed -$1.09M 70
2016
Q3
$1.09M Sell
14,824
-339
-2% -$27.5K 0.41% 58
2016
Q2
$1.26M Sell
15,163
-771
-5% -$68.4K 0.47% 50
2016
Q1
$1.52M Sell
15,934
-527
-3% -$47.5K 0.59% 42
2015
Q4
$1.6M Sell
16,461
-3,127
-16% -$325K 0.63% 41
2015
Q3
$1.92M Buy
19,588
+93
+0.5% +$10.3K 0.69% 39
2015
Q2
$2.25M Sell
19,495
-914
-4% -$99.9K 0.76% 32
2015
Q1
$2M Sell
20,409
-681
-3% -$69.2K 0.65% 43
2014
Q4
$1.99M Buy
+21,090
New +$2.18M 0.65% 43

Other funds holding GILD

Jackson Wealth Management's GILD Position: Q3 2025 in Review

Jackson Wealth Management sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 4,747 shares — an estimated $526K sold.

Jackson Wealth Management first reported a position in GILD in Q4 2014 and held it in 13 quarters. The position peaked at $2.25M in Q2 2015. 2,033 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Jackson Wealth Management reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Jackson Wealth Management sold 4,747 Gilead Sciences shares in Q3 2025, an estimated $526K.
  • Jackson Wealth Management first reported a position in Gilead Sciences in Q4 2014 and held it in 13 quarters.
  • Jackson Wealth Management's Gilead Sciences position peaked at $2.25M in Q2 2015.
  • 2,033 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Jackson Wealth Management's 13F filing for Q3 2025, filed 3 Oct 2025.